Explore

Reuters Reuters
California's highest court to consider whether drugmakers have 'duty to innovate'

California's highest court to consider whether drugmakers have 'duty to innovate'

May 6 (Reuters) - The California Supreme Court will on Wednesday consider whether manufacturers of drugs that are considered safe are legally obligated to continue developing drugs that are allegedly safer.
Reuters Reuters
Disney earnings beat estimates as new CEO outlines growth strategy

Disney earnings beat estimates as new CEO outlines growth strategy

By Lisa Richwine LOS ANGELES, May 6 (Reuters) - Walt Disney exceeded Wall Street's quarterly earnings estimates on Wednesday as streaming and theme park revenue rose, and new Chief Executive Josh D'Amaro reiterated that the company expected growth to accelerate in the second half of the fiscal year.
Reuters Reuters
Papa John's misses quarterly results estimates as living costs soar

Papa John's misses quarterly results estimates as living costs soar

May 7 (Reuters) - Papa John's International missed expectations for first-quarter revenue and profit on Thursday as the pizza chain failed to draw diners, especially in its U.S. market, at a time when consumers struggle with high living costs.
Reuters Reuters
Analysis-Novo and Lilly gain on signs weight-loss pills could expand the market

Analysis-Novo and Lilly gain on signs weight-loss pills could expand the market

By Bhanvi Satija, Stine Jacobsen and Maggie Fick LONDON/COPENHAGEN, May 7 (Reuters) - Early data from weight-loss pills are lifting shares in Novo Nordisk and Eli Lilly as investors bet that easier-to-take drugs could expand the market to millions more patients and help counter pricing pressure.
Reuters Reuters
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June launch, but U.S. health providers say not all patients are interested in the new option and those who want to try it can face insurance coverage gaps.
Reuters Reuters
Vertex tops profit estimates as sales of new cystic fibrosis drug surge

Vertex tops profit estimates as sales of new cystic fibrosis drug surge

May 4 (Reuters) - Vertex Pharmaceuticals on Monday beat Wall Street estimates for first-quarter adjusted profit, helped by a near eight-fold surge in sales of its new cystic fibrosis treatment.
Reuters Reuters
Pfizer pins post 2028 return to growth on new obesity and cancer drugs

Pfizer pins post 2028 return to growth on new obesity and cancer drugs

By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth after 2028, driven by obesity drugs in development, a patent extension for its heart drug Vyndamax and a favorable European court ruling on its COVID-19 vaccine.
Reuters Reuters
Alphabet closes in on Nvidia's spot as world's biggest company

Alphabet closes in on Nvidia's spot as world's biggest company

By Shashwat Chauhan May 5 (Reuters) - Alphabet is on the cusp of overtaking Nvidia as the world's most valuable company, riding on a record stock rally fueled by its artificial intelligence efforts and booming cloud business.
Reuters Reuters
Novo Nordisk's weight-loss pill boom faces price war test

Novo Nordisk's weight-loss pill boom faces price war test

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies.
Trendline Trendline
Pfizer Exceeds Wall Street Expectations with Strong Q1 Earnings and Revenue Growth

Pfizer Exceeds Wall Street Expectations with Strong Q1 Earnings and Revenue Growth

Pfizer Exceeds Wall Street Expectations with Strong Q1 Earnings and Revenue Growth
Reuters Reuters
Paramount Skydance first-quarter profit benefits from cost-cutting

Paramount Skydance first-quarter profit benefits from cost-cutting

By Dawn Chmielewski May 4 (Reuters) - Paramount Skydance's pre-tax earnings rose in the first quarter, the company said on Monday, as streamlined operations and improved results in its streaming and studios businesses helped offset declines in television.
Reuters Reuters
Live Nation posts upbeat quarterly revenue on steady demand for concerts

Live Nation posts upbeat quarterly revenue on steady demand for concerts

May 5 (Reuters) - Live Nation Entertainment beat analysts' estimates for first-quarter revenue on Tuesday, underscoring steady demand for concerts and live events even as the Ticketmaster parent faces mounting regulatory and legal scrutiny.